BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

587 related articles for article (PubMed ID: 10362249)

  • 21. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents.
    Fan S; el-Deiry WS; Bae I; Freeman J; Jondle D; Bhatia K; Fornace AJ; Magrath I; Kohn KW; O'Connor PM
    Cancer Res; 1994 Nov; 54(22):5824-30. PubMed ID: 7954409
    [TBL] [Abstract][Full Text] [Related]  

  • 22. v-Jun stimulates both cdk2 kinase activity and G1/S progression via transcriptional repression of p21 CIP1.
    Maclaren A; Clark W; Black EJ; Gregory D; Fujii H; Gillespie DA
    Oncogene; 2003 Apr; 22(16):2383-95. PubMed ID: 12717415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RhoA stimulates IEC-6 cell proliferation by increasing polyamine-dependent Cdk2 activity.
    Guo H; Ray RM; Johnson LR
    Am J Physiol Gastrointest Liver Physiol; 2003 Oct; 285(4):G704-13. PubMed ID: 12816757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Microinjection of anti-p21 antibodies induces senescent Hs68 human fibroblasts to synthesize DNA but not to divide.
    Ma Y; Prigent SA; Born TL; Monell CR; Feramisco JR; Bertolaet BL
    Cancer Res; 1999 Oct; 59(20):5341-8. PubMed ID: 10537318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mitomycin C and doxorubicin elicit conflicting signals by causing accumulation of cyclin E prior to p21WAF1/CIP1 elevation in human hepatocellular carcinoma cells.
    Choi SY; Shen YN; Woo SR; Yun M; Park JE; Ju YJ; Jeong J; Shin HJ; Joo HY; Park ER; Lee JK; Kim SH; Cho MH; Kong IS; Lee KH
    Int J Oncol; 2012 Jan; 40(1):277-86. PubMed ID: 21887464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of ectopic overexpression of p21(WAF1/CIP1) on aneuploidy and the malignant phenotype of human brain tumor cells.
    Chen J; Willingham T; Shuford M; Bruce D; Rushing E; Smith Y; Nisen PD
    Oncogene; 1996 Oct; 13(7):1395-403. PubMed ID: 8875977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. p21WAF1/CIP1/SDI1 is elevated through a p53-independent pathway by mimosine.
    Alpan RS; Pardee AB
    Cell Growth Differ; 1996 Jul; 7(7):893-901. PubMed ID: 8809407
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The lack of G1/S arrest of teratocarcinoma F9 cells is determinated by degradation of cyclin-dependent kinases inhibitor p21waf1/cip1].
    Malashicheva AB; Kisliakova TV; Pospelov VA
    Tsitologiia; 2000; 42(5):433-40. PubMed ID: 10890048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dissociation between cell cycle arrest and apoptosis can occur in Li-Fraumeni cells heterozygous for p53 gene mutations.
    Delia D; Goi K; Mizutani S; Yamada T; Aiello A; Fontanella E; Lamorte G; Iwata S; Ishioka C; Krajewski S; Reed JC; Pierotti MA
    Oncogene; 1997 May; 14(18):2137-47. PubMed ID: 9174049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Posttranscriptional stabilization underlies p53-independent induction of p21WAF1/CIP1/SDI1 in differentiating human leukemic cells.
    Schwaller J; Koeffler HP; Niklaus G; Loetscher P; Nagel S; Fey MF; Tobler A
    J Clin Invest; 1995 Mar; 95(3):973-9. PubMed ID: 7883998
    [TBL] [Abstract][Full Text] [Related]  

  • 31. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
    Huang S; Liu LN; Hosoi H; Dilling MB; Shikata T; Houghton PJ
    Cancer Res; 2001 Apr; 61(8):3373-81. PubMed ID: 11309295
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Expression of sdi1, a potent inhibitor of cdk2 kinase, cdk2 and G1 cyclins and mutation of sdi1 in human gastric carcinomas].
    Akama Y; Yasui W; Kuniyasu H; Yokozaki H; Tahara H; Noda A; Tahara E
    Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():180. PubMed ID: 7611786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role for c-Abl tyrosine kinase in growth arrest response to DNA damage.
    Yuan ZM; Huang Y; Whang Y; Sawyers C; Weichselbaum R; Kharbanda S; Kufe D
    Nature; 1996 Jul; 382(6588):272-4. PubMed ID: 8717045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p53-independent regulation of p21Waf1/Cip1 expression and senescence by Chk2.
    Aliouat-Denis CM; Dendouga N; Van den Wyngaert I; Goehlmann H; Steller U; van de Weyer I; Van Slycken N; Andries L; Kass S; Luyten W; Janicot M; Vialard JE
    Mol Cancer Res; 2005 Nov; 3(11):627-34. PubMed ID: 16317088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transforming growth factor beta 1 increases the stability of p21/WAF1/CIP1 protein and inhibits CDK2 kinase activity in human colon carcinoma FET cells.
    Gong J; Ammanamanchi S; Ko TC; Brattain MG
    Cancer Res; 2003 Jun; 63(12):3340-6. PubMed ID: 12810668
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The differentiation primary response gene MyD118, related to GADD45, encodes for a nuclear protein which interacts with PCNA and p21WAF1/CIP1.
    Vairapandi M; Balliet AG; Fornace AJ; Hoffman B; Liebermann DA
    Oncogene; 1996 Jun; 12(12):2579-94. PubMed ID: 8700517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of p21Waf1/Cip1/Sdi1 in cell death and DNA repair as studied using a tetracycline-inducible system in p53-deficient cells.
    Sheikh MS; Chen YQ; Smith ML; Fornace AJ
    Oncogene; 1997 Apr; 14(15):1875-82. PubMed ID: 9150394
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The orphan receptor COUP-TFII regulates G2/M progression of breast cancer cells by modulating the expression/activity of p21(WAF1/CIP1), cyclin D1, and cdk2.
    Nakshatri H; Mendonca MS; Bhat-Nakshatri P; Patel NM; Goulet RJ; Cornetta K
    Biochem Biophys Res Commun; 2000 Apr; 270(3):1144-53. PubMed ID: 10772965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells.
    Damiens E; El Yazidi I; Mazurier J; Duthille I; Spik G; Boilly-Marer Y
    J Cell Biochem; 1999 Sep; 74(3):486-98. PubMed ID: 10412049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Induction of p53-independent p21 during ceramide-induced G1 arrest in human hepatocarcinoma cells.
    Kim WH; Kang KH; Kim MY; Choi KH
    Biochem Cell Biol; 2000; 78(2):127-35. PubMed ID: 10874474
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.